Leah Isakov is a senior leader in the pharmaceutical industry with a unique combination of leadership and technical skills. She has worked in clinical trials for more than two decades and is known for delivering results. Leah has led NDA (New Drug Applications), PMA (Pre-Marketing Approvals) and BLA (Biologics License Applications) and have deep experience interacting with all the major regulatory bodies (FDA, EMEA, PMDA, Russian Ministry of Health, and Health Canada). She also has direct experience successfully managing cross-cultural international teams (USA, China, Japan and Canada). The recent therapeutic areas include Oncology, Infectious Diseases, Cardiovascular, Asthma, Renal Failure and HIV for Phase II-IV clinical trials in drugs and biologics.


As a leader, Dr. Isakov strives to be at the forefront of management practice. She incorporates data-driven decision making and quantitative risk management, and focus on building internal capabilities along with external collaborations. Leah believes that successful management comes from understanding the full organisational stack; that is, not only high-level strategy but also the technical aspects that enable success.

After getting his Ph.D. in Algebraic Topology in 1983 Andrey worked in several scientific and/or teaching organisations, among them are the Russian Academy of Sciences, Moscow State University, and Baumann Technology University. The Scientific advising of the graduate and thesis students was part of his activities, not only in Russia, but also in France.

Andrey’s main results in science are linked with geophysical data processing, so naturally his teaching interests are now concentrated in the applied methods of Statistics and their algorithmic implementations. He currently helps his students avoid some common errors within the probabilistic inferences and support their attempts to study Probability and Statistics theory in general.